| 1 |
19299526 | In vitro and in silico identification and characterization of thiabendazole as a mechanism-based inhibitor of CYP1A2 and simulation of possible pharmacokinetic drug-drug interactions. | 2009 Jun |
4 |
| 2 |
19754423 | Synthetic and natural compounds that interact with human cytochrome P450 1A2 and implications in drug development. | 2009 |
1 |
| 3 |
18570159 | Effect of butylated hydroxytoluene, curcumin, propyl gallate and thiabendazole on cytochrome P450 forms in cultured human hepatocytes. | 2008 Jun |
2 |
| 4 |
16261361 | Artemisinin and thiabendazole are potent inhibitors of cytochrome P450 1A2 (CYP1A2) activity in humans. | 2005 Nov |
5 |
| 5 |
11124226 | Application of higher throughput screening (HTS) inhibition assays to evaluate the interaction of antiparasitic drugs with cytochrome P450s. | 2001 Jan |
2 |
| 6 |
10936227 | Evidence for cytochrome P4501A2-mediated protein covalent binding of thiabendazole and for its passive intestinal transport: use of human and rabbit derived cells. | 2000 Jul 3 |
5 |
| 7 |
9565779 | Identification of human and rabbit cytochromes P450 1A2 as major isoforms involved in thiabendazole 5-hydroxylation. | 1998 |
1 |